INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY

被引：0
|
作者：
Minard-Colin, V.
Auperin, A.
Burke, A.
Alexander, S.
Moreno, M.
Buffardi, S.
Uyttebroeck, A.
Bollard, C.
Zsiros, J.
Csoka, M.
Kazanowska, B.
Chiang, A.
Verschuur, A.
Miles, R.
Wotherspoon, A.
Barkauskas, D.
Wheatley, K.
Vassal, G.
Adamson, P.
Gross, T.
Patte, C.
Pillon, M.
机构：
来源：
LEUKEMIA RESEARCH | 2022年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
061
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [21] IMMUNE RECONSTITUTION IN PATIENTS WIHT B-NON HODGKIN LYMPHOMA (B-NHL) TREATED WITH RITUXIMAB, CHEMOTHERAPY OR BOTH - A COHORT STUDY
    Afonso, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 617 - 618
  • [22] The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM plus and CNS plus Mature B-NHL: A Children's Oncology Group Report
    Goldman, Stanton
    Galardy, Paul J.
    Smith, Lynette
    Perkins, Sherrie L.
    Shiramizu, Bruce
    Gross, Thomas
    Sanger, Warren G.
    Harrison, Lauren
    Cairo, Mitchell S.
    BLOOD, 2011, 118 (21) : 1161 - 1162
  • [23] RESULTS OF THE ADDITION OF RASBURICASE(RU) AND RITUXMAB(RM) TO THE FAB/LMB96 CHEMOTHERAPY BACKBONE IN CHILDREN plus ADOLESCENTS(C plus A) WITH MATURE B-NHL:A CHILDREN'S ONCOLOGY GROUP REPORT
    Cairo, Mitchell S.
    Lynch, James
    Harrison, Lauren
    Perkins, Sherrie
    Sanger, Warren
    Gross, Thomas
    Shiramizu, Bruce
    Goldman, Stanton
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 858 - 858
  • [24] Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial (vol 10, pg e445, 2023)
    Alexander, S.
    Auperin, A.
    Bomken, S.
    LANCET HAEMATOLOGY, 2023, 10 (06): : E399 - E399
  • [25] Outcome of advanced stage (III/IV) intermediate-risk patients with mature B-NHL using rituximab plus FAB group B4 chemotherapy: a Children's Oncology Group report
    Goldman, S.
    Smith, L.
    Anderson, J. R.
    Perkins, S.
    Harrison, L.
    Shiramizu, B.
    Sanger, W.
    Barth, M.
    Cairo, M. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 24 - 24
  • [26] OUTCOME AND PATTERNS OF FAILURE FOLLOWING COMBINED FAB CHEMOTHERAPY AND RITUXIMAB IN CHILDREN AND ADOLESCENTS WITH STAGE III/IV, BM+ AND/OR CNS+ MATURE B-NHL: A CHILDREN'S ONCOLOGY REPORT
    Goldman, S.
    Smith, L.
    Perkins, S. L.
    Shiramizu, B.
    Gross, T.
    Sanger, W.
    Harrison, L.
    Cairo, M. S.
    ANNALS OF ONCOLOGY, 2011, 22 : 176 - 176
  • [27] SURVIVAL IN CHILDREN AND ADOLESCENTS (C plus A) WITH MATURE B-NHL PROGRESSING OR RELAPSING FROM TREATMENT ON FAB/LMB 96: TUMOR BURDEN AND TIME TO RELAPSE ARE POOR PROGNOSTIC FACTORS
    Cairo, Mitchell S.
    Sposto, Richard
    Fan, Jin
    Gerrard, Mary
    Auperin, Anne
    Pinkerton, Ross
    McCarthy, Keith
    Raphael, Martine
    Harrison, Lauren
    Goldman, Stanton
    Patte, Catherine
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 855 - 855
  • [28] Therapy of Advanced-stage Mature B-cell Lymphoma and Leukemia in Children and Adolescents With Rituximab and Reduced Intensity Induction Chemotherapy (B-NHL 2004M Protocol): The Results of a Multicenter Study
    Samochatova, Elena V.
    Maschan, Alexey A.
    Shelikhova, Larisa N.
    Myakova, Natalia V.
    Belogurova, Margarita B.
    Khlebnikova, Olga P.
    Shamardina, Anastasia V.
    Ryskal, Olga V.
    Roumiantseva, Julia V.
    Konovalov, Dmitriy M.
    Dubrovina, Maria E.
    Rumyantsev, Alexander G.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (05) : 395 - 401
  • [29] The efficacy of rasburicase during COP reduction for the prevention of TLS in children and adolescents with newly diagnosed advanced stage mature B-NHL: a Children's Oncology Group report
    Hochberg, J. C.
    Galardy, P. J.
    Goldman, S.
    Perkins, S.
    Cairo, M. S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 26 - 26
  • [30] The Short-Term Efficacy and Safety of Obinutuzumab Plus Chemotherapy in B-NHL with High Tumor Burden: A Real-World, Retrospective Study
    Wan, Xin
    Guo, Wei
    Wang, Xingtong
    Zhao, Yangzhi
    Li, Jia
    Li, Junna
    Zhan, Zhumei
    Bai, Ou
    BLOOD, 2022, 140 : 11977 - 11978
12345